Drug General Information (ID: DDIVTAKCZR)
  Drug Name Minocycline Drug Info Tetraferric tricitrate decahydrate Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antibiotics Phosphate Binders
  Structure

 Mechanism of Minocycline-Tetraferric tricitrate decahydrate Interaction (Severity Level: Moderate)
     Complex formation Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Minocycline Tetraferric tricitrate decahydrate
      Mechanism Binds to polyvalent cations Polyvalent cations
      Key Mechanism Factor 1
Factor Name Chelation
Factor Description Chelation is a direct drug interaction that usually involves the formation of dimers or trimers, resulting in larger complexes and poorer absorption.
      Mechanism Description
  • Decreased absorption of Tetraferric tricitrate decahydrate due to formation of complexes caused by Minocycline 

Recommended Action
      Management Doxycycline should be administered at least one hour before ferric citrate according to the manufacturer. Omadacycline administration with ferric citrate should be separated by 4 hours. No recommendations are available for coadministration with other tetracyclines.

References
1 Product Information. Auryxia (ferric citrate). Keryx Biopharmaceuticals, Inc., New York, NY.
2 Product Information. Nuzyra (omadacycline). Paratek Pharmaceuticals, Inc., Boston, MA.
3 Product Information. Seysara (sarecycline). Allergan Inc, Irvine, CA.